M protein conserved region antibodies opsonise multiple strains of Streptococcus pyogenes with sequence variations in C-repeats.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Research in Microbiology

• Publication date

  2005-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.RESMIC.2004.12.009PMID 15862457
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection.

  2003cited by this paper
• Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope.

  2002cited by this paper
• Immunogenicity of a 26-Valent Group A Streptococcal Vaccine

  2002cited by this paper
• A half-century of streptococcal research: then & now.

  2002cited by this paper
• Rheumatic fever and rheumatic heart disease in India at the turn of the century.

  2001cited by this paper
• Pathogenesis of group A streptococcal infections.

  2000cited by this paper
• New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population

  2000cited by this paper
• Protective and Nonprotective Epitopes from Amino Termini of M Proteins from Australian Aboriginal Isolates and Reference Strains of Group A Streptococci

  2000cited by this paper
• Epidemiological Analysis of Non-M-Typeable Group A Streptococcus Isolates from a Thai Population in Northern Thailand

  2000cited by this paper
• Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments.

  1999cited by this paper
• Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus.

  1997cited by this paper
• Human antibodies to the conserved region of the M protein: opsonization of heterologous strains of group A streptococci.

  1997cited by this paper
• Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci

  1996cited by this paper
• Mapping a conserved conformational epitope from the M protein of group A streptococci.

  1996cited by this paper
• Recombinant, octavalent group A streptococcal M protein vaccine.

  1996cited by this paper
• Role of the conserved C‐repeat region of the M protein of Streptococcus pyogenes

  1995cited by this paper
• Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci.

  1994cited by this paper
• An M protein with a single C repeat prevents phagocytosis of Streptococcus pyogenes: use of a temperature‐sensitive shuttle vector to deliver homologous sequences to the chromosome of S. pyogenes

  1993cited by this paper
• Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever

  1989cited by this paper
• Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci

  1988cited by this paper

• Invasive Streptococcal Infection Can Lead to the Generation of Cross-Strain Opsonic Antibodies

  2022cites this paper
• M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP)

  2020cites this paper
• Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized mice

  2019cites this paper
• Semisynthetic, self-adjuvanting vaccine development: Efficient, site-specific sortase A-mediated conjugation of Toll-like receptor 2 ligand FSL-1 to recombinant protein antigens under native conditions and application to a model group A streptococcal vaccine.

  2019cites this paper
• Rheumatic Heart Disease ( RHD ) Prevention and Control in North India : Addressing the Challenges

  2016cites this paper
• Predicted Coverage and Immuno-Safety of a Recombinant C-Repeat Region Based Streptococcus pyogenes Vaccine Candidate

  2016cites this paper
• Immune response against M protein-conserved region peptides from prevalent group A Streptococcus in a North Indian population.

  2016cites this paper
• Site-specific incorporation of three toll-like receptor 2 targeting adjuvants into semisynthetic, molecularly defined nanoparticles: application to group a streptococcal vaccines.

  2014cites this paper
• Self-adjuvanting vaccine against group A streptococcus: application of fibrillized peptide and immunostimulatory lipid as adjuvant.

  2014cites this paper
• An efficient, chemically-defined semisynthetic lipid-adjuvanted nanoparticulate vaccine development system.

  2013cites this paper
• Immunogenicity of a divalent group A streptococcal vaccine

  2013cites this paper
• StreptInCor: A Candidate Vaccine Epitope against S. pyogenes Infections Induces Protection in Outbred Mice

  2013cites this paper
• Long-Term Antibody Memory Induced by Synthetic Peptide Vaccination Is Protective against Streptococcus pyogenes Infection and Is Independent of Memory T Cell Help

  2013cites this paper
• 56 – Streptococcus Group A Vaccines

  2013cites this paper
• Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-protein.

  2012cites this paper
• Self-adjuvanting polyacrylic nanoparticulate delivery system for group A streptococcus (GAS) vaccine.

  2011cites this paper
• Invasive infection caused by Streptococcus dysgalactiae subsp. equisimilis: characteristics of strains and clinical features

  2011cites this paper
• JJo, a Recombinant Dimer of Conformationally Restricted Peptide Elicits Protective Response against Group A Streptococcus (GAS) Isolates from a GAS-Endemic Region

  2011cites this paper
• Anti-Group A Streptococcal Vaccine Epitope

  2010cites this paper
• emm type distribution pattern of group A streptococcus in north India: need for a new preventive approach

  2010cites this paper
• Design of three-component vaccines against group A streptococcal infections: importance of spatial arrangement of vaccine components.

  2010cites this paper
• emm gene diversity, superantigen gene profiles and presence of SlaA among clinical isolates of group A, C and G streptococci from western Norway

  2010cites this paper
• Molecular and epidemiological aspects of Streptococcus pyogenes disease in Finland: Severe infections and bacterial, non-necrotizing cellulitis

  2009cites this paper
• emm and C-Repeat Region Molecular Typing of Beta-Hemolytic Streptococci in a Tropical Country: Implications for Vaccine Development

  2009influential citation
• Genetic diversity of Group A Streptococcus M protein: implications for typing and vaccine development.

  2008cites this paper
• Identification and molecular characterisation of a fibrinogen binding protein from Streptococcus iniae.

  2008cites this paper
• Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidates.

  2008cites this paper
• Pathogen Proteins Eliciting Antibodies Do Not Share Epitopes with Host Proteins: A Bioinformatics Approach

  2007cites this paper
• Group A streptococcus epidemiology and vaccine implications.

  2007cites this paper
• Analysis of the group A streptococcal surface protein, serum opacity factor as a vaccine antigen and virulence determinant

  2007cites this paper
• Hypoplastic left heart syndrome: Rheumatic heart disease of the fetus?

  2006cites this paper
• Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population

  2006influential citation
• Towards a Vaccine Against Rheumatic Fever

  2006cites this paper
• Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non‐opsonic epitopes

  2006cites this paper
• Toxic Shock Syndrome in Children

  2005cites this paper
• Is Independent of Memory T Cell Help Infection and Streptococcus Pyogenes against Synthetic Peptide Vaccination Is Protective Long-term Antibody Memory Induced By

  year unknowncites this paper
• MINI SYMPOSIUM: RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE

  year unknowncites this paper
• Is Independent of Memory T Cell Help Infection and Streptococcus Pyogenes against Synthetic Peptide Vaccination Is Protective Long-term Antibody Memory Induced By

  year unknowncites this paper